Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Does Cannabis Reduce the Number of Sleep Apnoea Events Per Night? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Obstructive sleep apnoea (OSA) is marked by repeated pauses in breathing during sleep, impacting overall health. Patients and researchers are exploring whether cannabis for apnoea events can help lower these episodes. Understanding its potential to improve sleep breathing is key. 

Am I eligible for medical cannabis for pain relief?

How Cannabis May Influence Sleep Apnoea 

Emerging studies suggest cannabis for apnoea events may play a role in stabilising respiration and reducing interruptions during sleep. 

Respiratory Muscle Support 

Cannabinoids could help maintain airway tone, potentially reducing apnoea frequency reduction. 

Improved Sleep Stability 

Some patients report fewer night-time awakenings, supporting sleep breathing with cannabis benefits. 

Reduction of Inflammatory Response 

Cannabis may lower airway inflammation, improving airflow and contributing to cannabis for apnoea events. 

Daytime Symptom Relief 

Patients sometimes experience less daytime fatigue, hinting at successful apnoea frequency reduction. 

Adjunct Therapy Potential 

Cannabis could complement existing OSA treatments, enhancing overall sleep quality through sleep breathing with cannabis. 

While preliminary findings suggest cannabis for apnoea events may reduce nightly breathing interruptions, more research is required to confirm effectiveness, ideal dosing, and long-term safety for apnoea frequency reduction. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea . 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories